Modern medicine has made extraordinary progress in treating disease. From cardiovascular interventions to targeted cancer therapies, many conditions that were once fatal are now manageable. Yet despite these advances, a fundamental pattern remains: most treatments address symptoms or late-stage pathology,…
Why Gene Therapy May Be The Wrong Tool For Telomerase
Advances in gene therapy have opened new possibilities for treating disease at its source. By introducing or modifying genetic material, these approaches offer the potential for long-lasting or even permanent biological effects. In many contexts, this represents a powerful and…
Control vs. Activation: The Missing Variable In Longevity Therapeutics
In science, it is not uncommon for early observations to shape entire fields—sometimes correctly, and sometimes incompletely. A classic example is the well-known correlation between ice cream sales and shark attacks. Both increase during the summer months, yet one does…
Why Telomerase Activation Has Been Misunderstood For Decades
For decades, telomerase has existed in a strange scientific limbo—recognized as essential to cellular function, yet widely viewed with suspicion. The prevailing narrative has been (too) simple: telomerase is active in cancer cells, therefore activating telomerase must increase cancer risk.…